Evidence map›Paper›PMID 36589248›Full record

ArticleVisceral medicine2022

Acute Mesenteric Ischemia: Preexisting Comorbidity Determines Short-Term Outcome and Quality of Life in Long-Term Survivors.

Maria Witte, Manuela Neese, Matthias Leuchter, Mark Philipp, Ernst Klar, Clemens Schafmayer

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Visceral medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Maria WitteDepartment of General, Visceral, Vascular, Thoracic and Transplant Surgery, University Medical Center Rostock, Rostock, Germany.
Manuela NeeseDepartment of General, Visceral, Vascular, Thoracic and Transplant Surgery, University Medical Center Rostock, Rostock, Germany.
Matthias LeuchterDepartment of General, Visceral, Vascular, Thoracic and Transplant Surgery, University Medical Center Rostock, Rostock, Germany.
Mark PhilippDepartment of General, Visceral, Vascular, Thoracic and Transplant Surgery, University Medical Center Rostock, Rostock, Germany.
Ernst KlarDepartment of General, Visceral, Vascular, Thoracic and Transplant Surgery, University Medical Center Rostock, Rostock, Germany.
Clemens SchafmayerDepartment of General, Visceral, Vascular, Thoracic and Transplant Surgery, University Medical Center Rostock, Rostock, Germany.
University of Rostock · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Acute mesenteric ischemia (AMI), either arterial or venous, is still a devastating disease with poor prognosis. It is unknown, whether AMI is associated with impaired quality of life (QoL) in long-term survivors. Material and Methods: This retrospective analysis includes 64 patients with occlusive arterial or venous mesenteric ischemia treated operatively between 2008 and 2016 at the University Medical Center Rostock. Short-term outcome with focus on comorbidities was measured by the Charlson comorbidity index (CCI) an instrument that operationally measures comorbidity based on 17 clinical parameters including age. Operative outcome in view of enterostomy placement and long-term outcome measured as QoL by the EQ-5D in the long-term survivors were evaluated. The EQ-5D is a standardized, self-reported five-dimension QoL questionnaire built to provide a simple and generic measure of health. Results: Thirty-day mortality was 60.9%, and in-hospital mortality was 70.3% ( Conclusion: Herein, we show for the first time that long-term QoL in patients with AMI is impaired but this impairment is not due to disease-specific aspects but rather general risk factors underlying the presence of a higher level of comorbidities at the time of AMI.

Indexed as

Acute mesenteric ischemiaCharlson comorbidity indexEQ-5DLong-term outcomeQuality of life

Identifiers

PMID36589248
PMCPMC9801324
OpenAlexW4312446701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.